newsfilter
← Latest News
Business Wire·

Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., (NASDAQ:FMI), F. Hoffmann-La Roche Ltd (Roche) and DIAN Diagnostics Group, Co., Ltd. (DIAN), today announced a three-party collaboration to integrate Foundation Medicine’s comprehensive genomic profiling (CGP) assays into clinical patient care in mainland China. Under the collaboration: